Sanofi Eczema Drug Dupixent Succeeds in Adolescents Study
Sanofi (SNY) announces positive results from a phase III study evaluating Dupixent for the treatment of moderate-to-severe atopic dermatiti.....»»
Regulators caused breakup of potential $750 million drug deal — now they"ve blessed company"s latest move
The South San Francisco company will get $150 million, same as Sanofi agreed to pay as part of an ill-fated deal announced a year ago......»»
Moderna TeenCOVE study of its COVID vaccine in adolescents meets endpoint
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Annovis jumps after Alzheimer"s drug shows 30% cognitive improvement in study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Sanofi to present data from Phase 1 AMEERA-1 study at ASCO
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Myovant"s stock falls after FDA puts partial clinical hold on trial for contraceptive candidate
Shares of Myovant Sciences Ltd. were down 5.7% in premarket trading on Wednesday after the company told investors that the Food and Drug Administration had placed a partial clinical hold on a study assessing an experimental birth c.....»»
Regeneron, Sanofi Phase 3 data show Dupixent reduced asthma attacks in children
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Pfizer-BioNTech COVID-19 Vaccine Gets FDA Emergency Approval For Age Group 12-15
The U.S. Food and Drug Administration on Monday approved the emergency use of Pfizer Inc. (NYSE: PFE) and BioNTech SE’s (NASDAQ: BNTX) COVID-19 vaccine in adolescents aged between 12 to 15 years. read more.....»»
Pfizer COVID-19 Vaccine Expected To Get FDA Emergency Approval For Age Group 12-15 Next Week
The Food and Drug Administration has plans to authorize the emergency use of Pfizer Inc (NYSE: PFE) and BioNTech SE's (NASDAQ: BNTX) jointly-developed COVID-19 vaccine in adolescents aged between 12 to 15 years, t read more.....»»
Sanofi agrees to make Moderna COVID-19 vaccine in the U.S. starting in September
French drug maker Sanofi S.A. has agreed to make Moderna Inc.'s COVID-19 vaccine at its site in Ridgefield, New Jersey, .....»»
A landmark study shows the main compound in magic mushrooms could rival a leading depression drug
For the first tim.....»»
Johnson & Johnson Becomes Third Company To Expand COVID-19 Vaccine Study To Adolescents
read more.....»»
BioNTech, Pfizer: "Positive" results of COVID-19 vaccine study in adolescents
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Ionis shares tumble 19% after Roche halts Phase 3 study for rare-disease drug
Shares of Ionis Pharmaceuticals Inc. were down 19.6% in premarket trading on Tuesday, the day after the company said Roche Holding AG decided to discontinue.....»»
Pfizer starts early-stage study of oral COVID-19 treatment
Shares of Pfizer Inc. were down 1.1% in trading on Tuesday after the drug maker said it initiated a Phase 1 cl.....»»
Ionis shares tumble19% after Roche halts Phase 3 study for rare-disease drug
Shares of Ionis Pharmaceuticals Inc. were down 19.6% in premarket trading on Tuesday, the day after the company said Roche Holding AG decided to discontinue.....»»
GSK Kick Starts Late-Stage Study With Medicago-Partnered COVID-19 Vaccine
GlaxoSmithKline Plc (NYSE: GSK) hopes for better luck with its second partner Medicago, after tripping up in a recent COVID-19 vaccine test with Sanofi SA (NASDAQ: read more.....»»
Regeneron/Sanofi Boast Positive Overall Survival Results In Late-Stage Cervical Cancer Study
Sanofi SA (NASDAQ: SNY) and Regeneron Pharmaceuticals Inc (NASDAQ: read more.....»»
Regeneron, Sanofi announce Libtayo study to be stopped early due to OS benefit
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
: Novavax stock rallies on COVID-19 vaccine study results
Novavax Inc. NVAX shares rallied in the extended session Thursday after the biotech drug maker said studies show its COVID-19 vaccine is highly effective. Novavax shares surged 17% after hours,.....»»
Regeneron, Sanofi announce FDA acceptance of Dupixent sBLA
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»